UCP2 and type 2 diabetes mellitus: The ucp2 promoter polymorphism modulates lipid levels in patients with type 2 diabetes (345, 422) and the presence of the A-allele contributes to the increased UCP2, decreased ADP/ATP ratio, and decreased GSIS in glucose-tolerant subjects (368).